Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/48523
Full metadata record
DC FieldValueLanguage
dc.contributor.authorNoethel, M.-
dc.contributor.authorSchmidt, A.-
dc.contributor.authorBloemer, H.-
dc.contributor.authorMulder, M. T.-
dc.contributor.authorVANMIERLO, Tim-
dc.contributor.authorFriedrichs, S.-
dc.contributor.authorVoortman, G.-
dc.contributor.authorGoody, P. R.-
dc.contributor.authorZimmer, S.-
dc.contributor.authorNickenig, G.-
dc.contributor.authorLuetjohann, D.-
dc.contributor.authorJehle, J.-
dc.date.accessioned2026-02-17T08:21:14Z-
dc.date.available2026-02-17T08:21:14Z-
dc.date.issued2025-
dc.date.submitted2026-02-16T17:31:09Z-
dc.identifier.citationEuropean heart journal, 46 (Supplement_1)-
dc.identifier.urihttp://hdl.handle.net/1942/48523-
dc.description.abstractFunding Acknowledgements: Type of funding sources: Public grant(s)-National budget only. Main funding source(s): TRR259 BONFOR Background: The liver X receptor-beta (LXRβ) is a regulator of inflammation and cellular cholesterol metabolism. Saringosterol is a ligand of LXR. Both, inflammation and lipid dysregulation promote calcific aortic valve stenosis (AS). Whether saringosterol alleviates AS through LXR signalling is unknown.-
dc.description.sponsorshipBONFOR; [TRR259]-
dc.language.isoen-
dc.publisherOXFORD UNIV PRESS-
dc.titlePrevention of aortic valve stenosis through modulation of LXRb using saringosterol-
dc.typeJournal Contribution-
dc.identifier.issueSupplement_1-
dc.identifier.volume46-
local.format.pages1-
local.bibliographicCitation.jcatM-
local.publisher.placeGREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND-
local.type.refereedRefereed-
local.type.specifiedMeeting Abstract-
dc.identifier.doi10.1093/eurheartj/ehaf784.4796-
dc.identifier.isi001675719600001-
local.provider.typewosris-
local.description.affiliation[Noethel, M.; Schmidt, A.; Bloemer, H.; Goody, P. R.; Zimmer, S.; Nickenig, G.; Jehle, J.] Univ Hosp Bonn, Heartctr Bonn, Bonn, Germany.-
local.description.affiliation[Mulder, M. T.; Voortman, G.] Erasmus Univ, Med Ctr, Sect Pharmacol & Vasc Med, Rotterdam, Netherlands.-
local.description.affiliation[Vanmierlo, T.] Hasselt Univ, Biomed Res Inst, European Grad Sch Neurosci, Dept Neurosci, Hasselt, Belgium.-
local.description.affiliation[Friedrichs, S.; Luetjohann, D.] Univ Hosp Bonn, Inst Clin Chem & Clin Pharmacol, Bonn, Germany.-
local.uhasselt.internationalyes-
item.fulltextWith Fulltext-
item.accessRightsOpen Access-
item.fullcitationNoethel, M.; Schmidt, A.; Bloemer, H.; Mulder, M. T.; VANMIERLO, Tim; Friedrichs, S.; Voortman, G.; Goody, P. R.; Zimmer, S.; Nickenig, G.; Luetjohann, D. & Jehle, J. (2025) Prevention of aortic valve stenosis through modulation of LXRb using saringosterol. In: European heart journal, 46 (Supplement_1).-
item.contributorNoethel, M.-
item.contributorSchmidt, A.-
item.contributorBloemer, H.-
item.contributorMulder, M. T.-
item.contributorVANMIERLO, Tim-
item.contributorFriedrichs, S.-
item.contributorVoortman, G.-
item.contributorGoody, P. R.-
item.contributorZimmer, S.-
item.contributorNickenig, G.-
item.contributorLuetjohann, D.-
item.contributorJehle, J.-
crisitem.journal.issn0195-668X-
crisitem.journal.eissn1522-9645-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
ehaf784.4796.pdfPublished version25.29 kBAdobe PDFView/Open
Show simple item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.